PA
CIVI

PharVision Advisers’s Civitas Resources CIVI Stock Holding History

PharVision Advisers’s Portfolio CIVI Stock Details CIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,404
Closed -$202K – 308
2024
Q4 		$202K Buy
+4,404
New +$219K 0.17% 303

Other funds holding CIVI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KEM
Kimmeridge Energy Management New York $299M AUM 36.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's CIVI Position: Q1 2025 in Review

PharVision Advisers sold out of Civitas Resources (CIVI) in Q1 2025, closing a stake of 4,404 shares — an estimated $202K sold.

PharVision Advisers first reported a position in CIVI in Q4 2024 and held it in 1 quarter. The position peaked at $202K in Q4 2024. 363 funds tracked by Wall St. Rank hold CIVI as of Q1 2025.

  • PharVision Advisers reported no remaining Civitas Resources position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 4,404 Civitas Resources shares in Q1 2025, an estimated $202K.
  • PharVision Advisers first reported a position in Civitas Resources in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Civitas Resources position peaked at $202K in Q4 2024.
  • 363 funds tracked by Wall St. Rank held Civitas Resources as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.